I guess only as recently as 2018 was it considered in such a format and as a real opportunity in the OSA space
approved in 1985 as a nausea treatment for HIV so its been around a while for sure
Cannabinoids as patient medications will be potentially a huge drug opportunity for first movers in the space.... combine dronabinol ( synthetic cannabinoid) with acetazolamide......pure genius in my book Incannex....bring it on